title: Opposite effects of osteogenic protein and transforming growth factor beta on chondrogenesis in cultured long bone rudiments.
abstract: Osteogenic protein-1 (OP-1, also called BMP-7) is a bone morphogenetic member of the TGF-beta superfamily. In the present study, we examined the effect of recombinant human OP-1 on cartilage and bone formation in organ cultures of metatarsal long bones of mouse embryos and compared the OP-1 effects with those of human TGF-beta 1 and porcine TGF-beta 1 and beta 2. Cartilage formation was determined by measurement of longitudinal growth of whole bone rudiments during culture and by the incorporation of 35SO4 into glycosaminoglycans. Mineralization was monitored by 45Ca incorporation in the acid-soluble fraction and by measuring the length of the calcifying center of the rudiment. Toluidine blue-stained histologic sections were used for quantitative histomorphometric analysis. We found that OP-1 stimulated cartilage growth as determined by sulfate incorporation and that it increased remarkably the width of the long bones ends compared with controls. This effect was partly caused by differentiation of perichondrial cells into chondrocytes, resulting in increased appositional growth. In contrast to OP-1, TGF-beta 1 and beta 2 inhibited cartilage growth and reduced the length of whole bone rudiments compared with controls. In the ossifying center of the bone rudiments, both OP-1 and TGF-beta inhibited cartilage hypertrophy, growth of the bone collar, and matrix mineralization. These data demonstrate that OP-1 and TGF-beta exhibit opposite effects on cartilage growth but similar effects on osteogenesis in embryonic mouse long bone cultures. Since both OP-1 and TGF-beta have been demonstrated in embryonic cartilage and bone, these results suggest that they act as autocrine or paracrine regulators of embryonic bone development.
authors.affiliation: Department of Oral Cell Biology, Vrije Universiteit, Amsterdam, The Netherlands.
authors.forename: S C
authors.initials: SC
authors.lastname: Dieudonné
authors.forename: C M
authors.initials: CM
authors.lastname: Semeins
authors.forename: S W
authors.initials: SW
authors.lastname: Goei
authors.forename: S
authors.initials: S
authors.lastname: Vukicevic
authors.forename: J K
authors.initials: JK
authors.lastname: Nulend
authors.forename: T K
authors.initials: TK
authors.lastname: Sampath
authors.forename: M
authors.initials: M
authors.lastname: Helder
authors.forename: E H
authors.initials: EH
authors.lastname: Burger
mesh_terms: D000818:Animals; D001846:Bone Development / Q000187:drug effects*; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins; D002118:Calcium / Q000378:metabolism; D002356:Cartilage / Q000187:drug effects* / Q000196:embryology; D006025:Glycosaminoglycans / Q000378:metabolism; D006801:Humans; D008682:Metatarsal Bones / Q000187:drug effects* / Q000196:embryology / Q000378:metabolism; D051379:Mice; D009924:Organ Culture Techniques; D011506:Proteins / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000494:pharmacology; D016212:Transforming Growth Factor beta / Q000494:pharmacology*
chemical_list: C525819:BMP7 protein, human; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins; D006025:Glycosaminoglycans; D011506:Proteins; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; D002118:Calcium